CYP1A1 and breast carcinoma: According to a recent study, when MCF-7 breast cancer cells were treated with HSP (1–20 μM), aryl hydrocarbon receptor (Ahr) was inhibited, and the expression of CYP1A1, 1A2, and 1B1 was downregulated [143].